CROS NT
Partners & Customers
3About CROS NT
CROS NT is a global Contract Research Organization (CRO) specialized in clinical data services. With over 800 studies completed in a variety of therapeutic areas and indications, CROS NT has remained focused on biometrics including statistical consultancy, programming and analysis, clinical data management, medical writing, pharmacovigilance and life science technology solutions. It collects, integrates and analyzes data from various sources and uses processes and technology to ensure excellent project governance, reporting, and traceability.On June 8th, 2021, CROS NT was acquired by Alira Health. The terms of the transaction were not disclosed.
CROS NT Headquarter Location
Via Germania 2
Verona, 37136,
Italy
+39 045 820 26 66
Latest CROS NT News
Oct 22, 2021
PharmiWeb.Jobs Welcomes Cros NT CROS NT in their Own Words We are a global team of passionate specialists delivering innovative, high quality, tailored biometrics solutions. We support you in developing therapeutics for patients in a smarter manner by facilitating digital technologies, data integration, standardisation, visualisation and analytics, and data oversight. As biometrics specialists we have made a difference to over 500 projects, by minimising risk, increasing insight and maximising outcomes for patients. Our core expertise spans clinical data management, biostatistics and statistical programming, with our work on centralised biometrics gaining recognition industry-wide. At CROS NT, our mission is to support our clients in developing therapeutics for patients in a smart, innovative and cost-efficient manner through data-driven expertise, solutions and technology. Editor Details PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.8.2.1 You are leaving PharmiWeb.com Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com. PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue
CROS NT Acquisitions
2 Acquisitions
CROS NT acquired 2 companies. Their latest acquisition was PM Clinical - Clinical Division on March 07, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/7/2017 | Acquired Unit | 1 | ||||
9/11/2013 |
Date | 3/7/2017 | 9/11/2013 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acquired Unit | |
Sources | 1 |
CROS NT Partners & Customers
3 Partners and customers
CROS NT has 3 strategic partners and customers. CROS NT recently partnered with Medidata Solutions on May 5, 2017.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
5/23/2017 | Partner | United States | CROS NT Announces Extended Partnership with Medidata – Deploys RaveX. 23 May 2017 -- CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata . | 2 | |
1/31/2017 | Partner | ||||
8/5/2013 | Partner |
Date | 5/23/2017 | 1/31/2017 | 8/5/2013 |
|---|---|---|---|
Type | Partner | Partner | Partner |
Business Partner | |||
Country | United States | ||
News Snippet | CROS NT Announces Extended Partnership with Medidata – Deploys RaveX. 23 May 2017 -- CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata . | ||
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.